Alphaherpesvirus reactivation from thoracic sympathetic ganglia (TSG) and transaxonal spread to target organs cause human visceral disease. Yet alphaherpesvirus latency in TSG has not been well characterized. In this study, quantitative PCR detected varicella-zoster virus (VZV), herpes simplex virus 1 (HSV-1), and HSV-2 DNA in 117 fresh TSG obtained postmortem from 15 subjects. VZV DNA was found in 76 (65%) ganglia from all subjects, HSV-1 DNA was found in 5 (4%) ganglia from 3 subjects, and no HSV-2 was found.
HSV-1 DNA was found in nodose ganglia of 1/11 (9%) subjects but not in celiac ganglia. Subsequent PCR analysis of fresh postmortem sympathetic ganglia did not detect VZV DNA in three subjects but did reveal HSV-1 DNA in two subjects; unfortunately, the type of sympathetic ganglia obtained was not identified (10) . More recent analyses of multiple fixed human autonomic ganglia revealed VZV and HSV-1 DNA, respectively, in 11/58 and 23/58 pterygopalatine ganglia, in 14/60 and 25/60 ciliary ganglia, in 8/50 and 15/50 otic ganglia, in 4/47 and 14/47 submandibular ganglia, in 10/58 and 18/58 superior cervical ganglia, and in 1/36 and 12/36 nodose ganglia (7). Our detection of VZV DNA in greater numbers of freshly isolated TSG clearly indicates that the VZV DNA is from VZV viremia in childhood; the presence of HSV-1 and HSV-2 DNA is rare to nonexistent, with HSV-1 latency mostly limited to cranial nerve ganglia and HSV-2 mostly limited to sacral ganglia, presumably after retrograde transaxonal transport of virus from the face to cranial nerve ganglia. Our current detection of VZV DNA in TSG from 100% of the subjects most likely reflects enhanced PCR amplification of DNA from fresh rather than FFPE tissue. Recently, VZV DNA was found in resected segments of gastrointestinal tract from 6/6 children with a history of varicella and in 6/7 children who received varicella vaccine but not in 7 children with no history of varicella or varicella vaccination (13) . Overall, VZV DNA is present not only in cranial nerve ganglia and dorsal root ganglia but also in sympathetic and parasympathetic ganglia of most humans as well as in the enteric nervous system. Importantly, TSG supply postganglionic fibers to blood vessels, skin, heart, lung, pancreas, gastrointestinal tract, liver, spleen, adrenal glands, kidneys, ureters, and bladder and also connect to dorsal root ganglia via gray communicating rami (14, 15) . Thus, virus reactivation from TSG and dorsal root ganglia followed by virus spread to target organs may provide a potential pathway for virus-induced visceral disease. This is supported by VZV-induced pancreatitis and the presence of VZV antigen, large basophilic inclusions, and Cowdry type A inclusion bodies in associated sympathetic ganglia of a patient with fatal VZV meningoradiculitis without skin involvement (16) , as well as ad- total of 117 TSG from 15 subjects were obtained. DNA was extracted from each ganglion and quantitative PCR (qPCR) was performed using VZV-specific primers and probe to determine viral DNA copy numbers per 100 ng of DNA. Each point represents one ganglion. Ganglia that did not contain VZV DNA are not shown. DNA copy numbers were determined using a standard curve for known viral DNA concentrations. Based on the standard curve, some samples had copy numbers of Ͻ100 (detectable but not quantifiable). VZV DNA was found in all 15 subjects and in 76 (65%) of the 117 ganglia.
FIG 2
Amplification plot derived from two human thoracic sympathetic ganglia that contained low-abundance VZV DNA with corresponding standard curves using known concentrations of VZV DNA. Black squares (Ն100 copies of VZV DNA) reflect duplicate data points; circles around black squares on the standard curves indicate single data point (10 copies of VZV DNA). Arrows indicate duplicate thoracic sympathetic ganglionic samples containing 10 to 100 copies of VZV DNA that are denoted as Ͻ100 copies in Table 2. ditional reports of zoster-associated pancreatitis and hepatitis, and the presence of VZV DNA and VZV antigen in biopsy specimens of patients with zoster-associated gastritis (17) (18) (19) (20) (21) (22) (23) .
VZV is well known to reactivate in the absence of rash (24) . Two reports describe VZV-verified hepatitis and gastritis without rash in bone marrow transplant recipients. The first report was of a 74-year-old patient with common variable immunodeficiency of uncertain origin who died of fulminant hepatic failure, and VZV DNA was found in the blood and liver (25) ; serum of the second patient contained anti-VZV IgM antibody, and the patient was successfully treated with intravenous acyclovir (19) . Finally, there is a remarkable report of VZV reactivation from multiple ganglia in a patient who developed right thoracic zoster sine herpete, followed 6 days later by left thoracic-distribution zoster associated with pancreatitis, cholecystitis, and gastric ulcerations that contained VZV DNA (21) .
